Literature DB >> 914971

Pubertal progression in the presence of elevated serum gonadotropins in girls with multiple endocrine deficiencies.

A W Lucky, R W Rebar, R M Blizzard, E M Goren.   

Abstract

Pubertal progression in the presence of abnormally elevated serum gonadotropins was followed over several years in two girls with multiple endocrine deficiencies and mucocutaneous candidiasis. Both had hypoparathyroidism and one had adrenal failure as well. A serum level of progesterone (8 ng/ml) consistent with ovulation was documented in the one girl who had regular monthly menses. High serum levels of FSH (30--60 mIU/ml) at times when serum estradiol was in the normal pubertal range (100--200 pg/ml) may indicate partial ovarian end-organ resistance or failure. Since premature menopause is associated with this syndrome, we postulate that we are observing puberty in girls whose ovaries are in the early stages of a destructive process which may eventually result in irreversible ovarian failure. A possible explanation could be the existence of increased resistance to gonadotropins at the ovarian level because of gonadotropin receptor antibodies or an inherent receptor defect.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 914971     DOI: 10.1210/jcem-45-4-673

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Antiovarian antibodies in primary Sjogren's syndrome.

Authors:  Kyriaki Euthymiopoulou; Alexios J Aletras; Panagiota Ravazoula; Anna Niarakis; Dimitris Daoussis; Ioannis Antonopoulos; Stamatis-Nick Liossis; Andrew P Andonopoulos
Journal:  Rheumatol Int       Date:  2007-05-31       Impact factor: 2.631

Review 2.  Chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

3.  Clinical presentation, growth, and pubertal development in Addison's disease.

Authors:  D B Grant; N D Barnes; M W Moncrieff; M O Savage
Journal:  Arch Dis Child       Date:  1985-10       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.